These alterations affected genes known to be frequently involved in lung cancer, such as EGFR/HER1, CCNE1, or KRAS. In addition, the paper describes a novel player in lung cancer pathophysiology, the NKX2-1 gene product, a transcription factor implicated in the formation of lung pneumocytes. Here, NKX2-1 is linked to lung carcinoma.